Optiscan Biomedical
UK, GB · 3 known investors
Find your way into Optiscan Biomedical
Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.
Founders & leadership
Board
AP
ADITYA PURIBoard director
KA
KENNETH ABRAMOWITZBoard director
PM
PAUL MIEYALBoard director
CL
CHARLES LIAMOSBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$64.3M disclosed across 3 rounds · 2016–2019
▶$20MraisedMar 2019 · 10 investors · Other Health CareRule 506(b)
▶$20MraisedMar 2019 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- PAUL MIEYALDirector
- CARY VANCEExecutive Officer, Director
- ADITYA PURIDirector
- SCOTT HALSTEDDirector
- PATRICK NUGENTExecutive Officer
- KENNETH ABRAMOWITZDirector
- CHARLES LIAMOSDirector
- Offering amount
- $25.1M
- Amount sold
- $20M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.8MraisedFeb 2018 · 10 investors · Other Health CareRule 506(b)
▶$14.8MraisedFeb 2018 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- SCOTT HALSTEDDirector
- PAUL MIEYALDirector
- CHARLES LIAMOSDirector
- ADITYA PURIDirector
- KENNETH ABRAMOWITZDirector
- DONALD WEBBERExecutive Officer
- PATRICK NUGENTExecutive Officer
- WILLIAM MINCEExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $14.8M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.5MraisedJun 2016 · 16 investors · BiotechnologyRule 506(b)
▶$29.5MraisedJun 2016 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JIM CAUSEYExecutive Officer
- ADITYA PURIDirector
- PETER RULEExecutive Officer, Director
- KENNETH ABRAMOWITZDirector
- CHARLES LIAMOSDirector
- PATRICK NUGENTExecutive Officer
- PAUL MIEYALDirector
- DONALD WEBBERExecutive Officer
- Offering amount
- $40.1M
- Amount sold
- $29.5M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Optiscan Biomedical do?
- Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.
- Who are Optiscan Biomedical's investors?
- Optiscan Biomedical's investors include Ascension Ventures, BioBrit, Signet Healthcare Partners.
- How much funding has Optiscan Biomedical raised?
- Optiscan Biomedical has disclosed $64.3M raised across 3 rounds.
- Where is Optiscan Biomedical headquartered?
- Optiscan Biomedical is headquartered in UK, GB.